Advertisement
Research Article

Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

  • Emmanuel S. Onaivi mail,

    *E-mail: OnaiviE@wpunj.edu

    Affiliations: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America, Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse (NID)-National Institutes of Health (NIH), Bethesda, Maryland, United States of America

    X
  • Hiroki Ishiguro,

    Affiliations: Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse (NID)-National Institutes of Health (NIH), Bethesda, Maryland, United States of America, Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Japan

    X
  • Jian-Ping Gong,

    Affiliation: Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse (NID)-National Institutes of Health (NIH), Bethesda, Maryland, United States of America

    X
  • Sejal Patel,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Paul A. Meozzi,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Lester Myers,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Alex Perchuk,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Zoila Mora,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Patricia A. Tagliaferro,

    Affiliation: Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina

    X
  • Eileen Gardner,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Alicia Brusco,

    Affiliation: Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina

    X
  • B. Emmanuel Akinshola,

    Affiliation: Department of Pharmacology, Howard University, Washington, D. C., United States of America

    X
  • Bruce Hope,

    Affiliation: Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse (NID)-National Institutes of Health (NIH), Bethesda, Maryland, United States of America

    X
  • Javier Lujilde,

    Affiliation: Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina

    X
  • Toshiya Inada,

    Affiliation: Chiba Medical Center, Teikyo University, Ichihara, Chiba, Japan

    X
  • Shinya Iwasaki,

    Affiliation: Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse (NID)-National Institutes of Health (NIH), Bethesda, Maryland, United States of America

    X
  • David Macharia,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Lindsey Teasenfitz,

    Affiliation: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

    X
  • Tadao Arinami,

    Affiliation: Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse (NID)-National Institutes of Health (NIH), Bethesda, Maryland, United States of America

    X
  • George R. Uhl

    Affiliation: Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse (NID)-National Institutes of Health (NIH), Bethesda, Maryland, United States of America

    X
  • Published: February 20, 2008
  • DOI: 10.1371/journal.pone.0001640

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.